GleamWall
中文EN

OPK OPKO HEALTH, INC.

Pharmaceutical Preparations · Nasdaq · SEC CIK 944809 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-8.3%
TTM net income YoY17.9%
TTM EPS YoY24.0%
Revenue 3-yr CAGR-16.7%
Net income 3-yr CAGR—

Margins

Gross margin46.2%
Operating margin-25.5%
Net margin-29.5%
FCF margin-27.0%
EBITDA margin-8.3%

Returns

ROE-12.2%
ROA-7.6%
ROIC (approx.)-12.4%
Asset turnover0.26x

Leverage & solvency

Liabilities / assets40.6%
Debt / equity0.00x
Current ratio4.97x
Interest coverage2.08x

Cash quality & payout

Operating cash flow / net income0.84x
Accruals ratio-1.2%
Payout ratio—
Capex / revenue2.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$606.88M$713.14M
Cost of revenue$400.94M$494.63M
Gross profit$205.94M$218.51M
R&D expense$124.03M$105.21M
SG&A expense$223.00M$304.22M
Operating income-$117.41M-$152.06M
Interest expense$0$47.47M
Pretax income-$241.36M-$10.36M
Income tax-$15.71M$42.84M
Net income-$225.68M-$53.22M
EBITDA-$25.78M-$53.89M
EPS (basic)-0.30-0.08
EPS (diluted)-0.30-0.08
Weighted avg. shares (diluted)751.13M694.02M
Balance sheet
Cash & equivalents$364.41M$426.58M
Receivables$90.25M$118.02M
Inventory$52.73M$56.80M
Current assets$581.88M$662.09M
PP&E, net$72.81M$70.13M
Goodwill$320.85M$529.25M
Intangibles$446.43M$616.61M
Total assets$1.93B$2.20B
Current liabilities$146.68M$193.10M
Short-term debt$1.74M$437.20M
Long-term debt$2.26M$3.00M
Total debt$4.00M$440.20M
Total liabilities$663.98M$834.76M
Shareholders' equity$1.27B$1.37B
Net debt-$360.41M$13.62M
Cash flow statement
Operating cash flow-$178.54M-$183.49M
Capital expenditure$12.28M$25.01M
Free cash flow-$190.82M-$208.50M
Investing cash flow$230.30M$352.21M
Financing cash flow-$118.06M$184.17M
Depreciation & amortization$91.63M$98.18M
Stock-based compensation$10.71M$11.05M
Share buybacks$47.04M$90.22M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.